CC-401
Showing 1 - 25 of 1,116
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)
Terminated
- Multiple Myeloma
- SL-401/ Pomalidomide/ Dexamethasone
-
Duarte, California
- +2 more
Jan 13, 2022
Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma Trial in United States
Recruiting
- Angioimmunoblastic T-cell Lymphoma
- +6 more
- Cyclophosphamide
- +6 more
-
Los Angeles, California
- +20 more
Aug 2, 2022
Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)
Recruiting
- Hypercholesterolemia
- VXX-401
- Placebo
-
Sydney, New South Wales, Australia
- +2 more
Mar 15, 2023
Multiple Sclerosis Trial in Stockholm (Temelimab 18 mg/kg, Temelimab 36mg/kg, Temelimab 54 mg/kg)
Terminated
- Multiple Sclerosis
- Temelimab 18 mg/kg
- +2 more
-
Stockholm, SwedenCenter for Neurology, Academic Specialist Center
Jul 4, 2022
Rett Syndrome Trial in Aurora, Boston, Houston (NGN-401)
Recruiting
- Rett Syndrome
- NGN-401
-
Aurora, Colorado
- +2 more
Jun 12, 2023
Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- LIQ861
- (no location specified)
Nov 10, 2023
Hearing Loss Trial in Melbourne (SENS-401 (R-Azasetron Besylate))
Recruiting
- Hearing Loss
- SENS-401 (R-Azasetron Besylate)
-
Melbourne, AustraliaRoyal Victorian Eye and Ear Hospital
Jul 8, 2022
Detection and Characterization of Host Defense Defects
Recruiting
- Immune Defects
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- ME-401
- +2 more
-
Tucson, Arizona
- +23 more
Dec 14, 2021
Infections and Infection Susceptibility
Recruiting
- Immune Deficiencies
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023